🇺🇸 FDA
Patent

US 10294274

Polypeptide ligands specific for plasma kallikrein

granted A61KA61K38/00A61P

Quick answer

US patent 10294274 (Polypeptide ligands specific for plasma kallikrein) held by BicycleRD Limited expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BicycleRD Limited
Grant date
Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K38/00, A61P, A61P27/02, A61P29/00